Trial Profile
Sitagliptin Combo Study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs JNJ 38431055 (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2010 Planned number of patients changed from 20 to 2 as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.